Marcel Zwaal
Director Ejecutivo en Gadeta BV .
Cargos activos de Marcel Zwaal
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
Gadeta BV
Gadeta BV Medical SpecialtiesHealth Technology Gadeta BV discovers and develops novel cancer immunotherapies. It provides groundbreaking discoveries regarding the role of cell receptors in the broad of heamatological and solid tumor cells. The firm develops t-cells engineered to express a defined gamma delta, an anti- cancer product that eradicates tumors. The company was founded by Jurgen Kuball in 2015 and is headquartered in Utrecht, Netherlands. | Director Ejecutivo | 01/07/2021 | - |
Historial de carrera de Marcel Zwaal
Antiguos cargos conocidos de Marcel Zwaal.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
KIADIS PHARMA N.V. | Corporate Officer/Principal | 08/11/2018 | 13/07/2020 |
Hubrecht Organoid Technology Foundation | Director Ejecutivo | 01/09/2016 | 01/12/2017 |
Crucell NV
Crucell NV Pharmaceuticals: MajorHealth Technology Crucell NV develops, produces and markets vaccines, proteins and antibodies that prevent and treat infectious diseases. It focuses in the research & development of innovative immunization candidates to fight against tuberculosis, malaria, HIV/AIDS, influenza, rabies, polio and several other diseases which are the global health problems. The firms prod8ucts include Quinvaxem, Epaxal, Hepavax-Gene, Vivotif and Dukoral against paediatric, respiratory and travel or endemic infections. The company was founded by Domenico Valerio on October 9, 2000 and is headquartered in Leiden, Netherlands. | Corporate Officer/Principal | 01/01/2006 | - |
Philips Electronics Nederland BV
Philips Electronics Nederland BV Real Estate DevelopmentFinance Part of Koninklijke Philips NV, Philips Electronics Nederland BV owns, operates and leases nonresidential buildings. The company is based in Eindhoven, Netherlands. | Corporate Officer/Principal | - | - |
DCPrime BV
DCPrime BV Pharmaceuticals: MajorHealth Technology DCPrime BV engages in the provision of therapeutic vaccines for the treatment of cancer. It develops whole-cell-based vaccine addressing blood cancers with a high risk of relapse. The company was founded by Ada M. Kruisbeek and Rik J. Scheper in March 2005 and is headquartered in Leiden, the Netherlands. | Director Ejecutivo | 12/10/2012 | - |
Formación de Marcel Zwaal.
Vrije Universiteit Amsterdam | Graduate Degree |
Estadísticas
Internacional
Países Bajos | 7 |
Reino Unido | 2 |
Operativa
Chief Executive Officer | 3 |
Corporate Officer/Principal | 3 |
Graduate Degree | 1 |
Sectorial
Health Technology | 5 |
Consumer Services | 2 |
Finance | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas privadas | 6 |
---|---|
Crucell NV
Crucell NV Pharmaceuticals: MajorHealth Technology Crucell NV develops, produces and markets vaccines, proteins and antibodies that prevent and treat infectious diseases. It focuses in the research & development of innovative immunization candidates to fight against tuberculosis, malaria, HIV/AIDS, influenza, rabies, polio and several other diseases which are the global health problems. The firms prod8ucts include Quinvaxem, Epaxal, Hepavax-Gene, Vivotif and Dukoral against paediatric, respiratory and travel or endemic infections. The company was founded by Domenico Valerio on October 9, 2000 and is headquartered in Leiden, Netherlands. | Health Technology |
Philips Electronics Nederland BV
Philips Electronics Nederland BV Real Estate DevelopmentFinance Part of Koninklijke Philips NV, Philips Electronics Nederland BV owns, operates and leases nonresidential buildings. The company is based in Eindhoven, Netherlands. | Finance |
DCPrime BV
DCPrime BV Pharmaceuticals: MajorHealth Technology DCPrime BV engages in the provision of therapeutic vaccines for the treatment of cancer. It develops whole-cell-based vaccine addressing blood cancers with a high risk of relapse. The company was founded by Ada M. Kruisbeek and Rik J. Scheper in March 2005 and is headquartered in Leiden, the Netherlands. | Health Technology |
Kiadis Pharma NV
Kiadis Pharma NV Pharmaceuticals: MajorHealth Technology Kiadis Pharma NV engages in pharmaceutical development of cell-based immunotherapy products in the field of diseases of the blood building system. Its lead product is the ATIR101. The company was founded in 1997 and is headquartered in Amsterdam, the Netherlands. | Health Technology |
Gadeta BV
Gadeta BV Medical SpecialtiesHealth Technology Gadeta BV discovers and develops novel cancer immunotherapies. It provides groundbreaking discoveries regarding the role of cell receptors in the broad of heamatological and solid tumor cells. The firm develops t-cells engineered to express a defined gamma delta, an anti- cancer product that eradicates tumors. The company was founded by Jurgen Kuball in 2015 and is headquartered in Utrecht, Netherlands. | Health Technology |
Hubrecht Organoid Technology Foundation |
- Bolsa de valores
- Insiders
- Marcel Zwaal
- Experiencia